225 related articles for article (PubMed ID: 15533657)
21. Predicting and preventing the future: actively managing multiple sclerosis.
Hutchinson M
Pract Neurol; 2009 Jun; 9(3):133-43, discussion 144. PubMed ID: 19448055
[TBL] [Abstract][Full Text] [Related]
22. [Japanese originality, clinical symptoms to the causative gene 1 Segawa disease].
Segawa M
Rinsho Shinkeigaku; 2007 Nov; 47(11):730-4. PubMed ID: 18210786
[TBL] [Abstract][Full Text] [Related]
23. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
24. The physiological effects of pallidal deep brain stimulation in dystonia.
Tisch S; Rothwell JC; Limousin P; Hariz MI; Corcos DM
IEEE Trans Neural Syst Rehabil Eng; 2007 Jun; 15(2):166-72. PubMed ID: 17601185
[TBL] [Abstract][Full Text] [Related]
25. Rapidly progressive course of very late onset multiple sclerosis presenting with Parkinsonism: case report.
Schultheiss T; Reichmann H; Ziemssen T
Mult Scler; 2011 Feb; 17(2):245-9. PubMed ID: 20921234
[TBL] [Abstract][Full Text] [Related]
26. A new twist on the anatomy of dystonia: the basal ganglia and the cerebellum?
Jinnah HA; Hess EJ
Neurology; 2006 Nov; 67(10):1740-1. PubMed ID: 17130402
[No Abstract] [Full Text] [Related]
27. Generalised dystonia with an abnormal magnetic resonance imaging signal in the basal ganglia: a case of adult-onset GM1 gangliosidosis.
Campdelacreu J; Muñoz E; Gómez B; Pujol T; Chabás A; Tolosa E
Mov Disord; 2002 Sep; 17(5):1095-7. PubMed ID: 12360569
[TBL] [Abstract][Full Text] [Related]
28. Muscle atrophy associated with multiple sclerosis: a benign condition or the onset of amyotrophic lateral sclerosis?
Allen JA; Stein R; Baker RA; Royden Jones H
J Clin Neurosci; 2008 Jun; 15(6):706-8. PubMed ID: 18395451
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with the risk of secondary progression in multiple sclerosis.
Koch M; Uyttenboogaart M; van Harten A; De Keyser J
Mult Scler; 2008 Jul; 14(6):799-803. PubMed ID: 18573840
[TBL] [Abstract][Full Text] [Related]
30. [A patient with bilateral lesion in the striatum and slowly progressive dystonia secondary to T14487C mutation in the ND6 gene of complex I of the mitochondrial respiratory chain].
Raspall-Chaure M; Solano A; Vázquez E; Macaya-Ruiz A; del Toro-Riera M; Cabezuelo-Briones A; Montoya J; Andreu A; Roig-Quilis M
Rev Neurol; 2004 Dec 16-31; 39(12):1129-32. PubMed ID: 15625630
[TBL] [Abstract][Full Text] [Related]
31. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
32. [Disorders of higher motor function: changes in movement disorders with growth--age dependency of clinical findings in essential basal nuclei diseases].
Segawa M
Nihon Rinsho; 1987 Feb; 45(2):371-80. PubMed ID: 3553668
[No Abstract] [Full Text] [Related]
33. Late observation of the Goutières Aicardi syndrome.
Duffey P; Coulthard A; Burn DJ
Mov Disord; 1998 Jan; 13(1):179-82. PubMed ID: 9452350
[No Abstract] [Full Text] [Related]
34. Multiple sclerosis in Pakistan.
Wasay M; Ali S; Khatri IA; Hassan A; Asif M; Zakiullah N; Ahmed A; Malik A; Khealani B; Haq A; Fredrikson S
Mult Scler; 2007 Jun; 13(5):668-9. PubMed ID: 17548448
[TBL] [Abstract][Full Text] [Related]
35. Gender change and its impact on the course of multiple sclerosis.
Reske D; Haupt WF; Petereit HF
Acta Neurol Scand; 2006 May; 113(5):347-9. PubMed ID: 16629772
[TBL] [Abstract][Full Text] [Related]
36. Hemibody mirror movements in hemiparkinsonism-hemiatrophy syndrome.
Silvers DS; Menkes DL
J Neurol Sci; 2009 Dec; 287(1-2):260-3. PubMed ID: 19766249
[TBL] [Abstract][Full Text] [Related]
37. A secondary progressive clinical course is uncommon in neuromyelitis optica.
Wingerchuk DM; Pittock SJ; Lucchinetti CF; Lennon VA; Weinshenker BG
Neurology; 2007 Feb; 68(8):603-5. PubMed ID: 17310032
[TBL] [Abstract][Full Text] [Related]
38. Can spasticity and dystonia be independently measured in cerebral palsy?
Gordon LM; Keller JL; Stashinko EE; Hoon AH; Bastian AJ
Pediatr Neurol; 2006 Dec; 35(6):375-81. PubMed ID: 17138005
[TBL] [Abstract][Full Text] [Related]
39. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
40. Dystonia and other deformities in Parkinson's disease.
Jankovic J
J Neurol Sci; 2005 Dec; 239(1):1-3. PubMed ID: 16199057
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
